A Pedometer-based Intervention With and Without Email Counselling in General Practice

April 26, 2017 updated by: Tomáš Větrovský, Charles University, Czech Republic

A Pedometer-based Walking Intervention With and Without Email Counselling in General Practice: a Pilot Randomised Controlled Trial

A two-arm parallel randomised controlled trial comparing pedometer-based intervention with and without email counselling in a primary care setting. Physically inactive patients from four general practices will be randomised to the pedometer-plus-email group or to the pedometer-alone group. All patients will be instructed to gradually increase the daily number of steps to at least 10,000. Patients in the pedometer-plus-email group will receive 8 counselling emails based on behavioural techniques. The primary outcome will be change in average daily steps measured during 7-day period at baseline and at 12 weeks.

Study Overview

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • physically inactive, i.e. takes less than 8,000 steps per day at baseline
  • registered at the participating general practice,
  • over 18 years of age,
  • regular email user, and willing to use email for the purpose of the study,
  • has a home computer with access to the Internet.

Exclusion Criteria:

  • medical or psychiatric condition which the general practitioner considers as inappropriate for participating in the intervention (e.g., terminal illness, psychotic illness, chronic disorders or diseases that seriously influence the ability to be physically active, dementia or significant cognitive impairment, unable to move about independently),
  • medical, personal of family condition which the general practitioner considers temporarily affects mean daily step count at baseline (e.g., acute illness, holiday or business trip),
  • pregnant woman,
  • currently engaging in regular sports or exercise (at least twice a week),
  • failure to upload pedometer data to a website at baseline assessment,
  • failure to give informed consent with the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: pedometer-plus-email
After randomisation, participants will receive a pedometer and will be instructed to wear the pedometer daily for the next four months, check the step count every evening and gradually increase their daily number of steps to at least 10,000. They will also be required to upload data to a website at least once a week. During the intervention period, patients will receive 8 counselling emails based on behavioural techniques.
Active Comparator: pedometer-only
After randomisation, participants will receive a pedometer and will be instructed to wear the pedometer daily for the next four months, check the step count every evening and gradually increase their daily number of steps to at least 10,000. They will also be required to upload data to a website at least once a week. There will be no further interaction during the intervention period unless they fail to upload data, in which case they will be offered technical support.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
average daily step count
Time Frame: 12 weeks
change in average daily steps measured during 7-day period at baseline and at 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
body weight
Time Frame: 12 weeks
measured to the nearest kg
12 weeks
systolic blood pressure
Time Frame: 12 weeks
measured to the nearest mmHg
12 weeks
diastolic blood pressure
Time Frame: 12 weeks
measured to the nearest mmHg
12 weeks
waist circumference
Time Frame: 12 weeks
recorded with a measurement tape to the nearest cm
12 weeks
hip circumference
Time Frame: 12 weeks
recorded with a measurement tape to the nearest cm
12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
health-related quality of life
Time Frame: 12 weeks
assessed with the 36-Item Short Form Health Survey (SF-36)
12 weeks
anxiety
Time Frame: 12 weeks
assessed with the anxiety subscale of the Hospital Anxiety and Depression Scale
12 weeks
depression
Time Frame: 12 weeks
assessed with the depression subscale of the Hospital Anxiety and Depression Scale
12 weeks
self-efficacy
Time Frame: 12 weeks
assessed with the Czech version of the General Self-Efficacy scale
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tomas Vetrovsky, MD, Charles University, Czech Republic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2015

Primary Completion (Actual)

September 29, 2016

Study Completion (Actual)

December 9, 2016

Study Registration Dates

First Submitted

April 26, 2017

First Submitted That Met QC Criteria

April 26, 2017

First Posted (Actual)

May 1, 2017

Study Record Updates

Last Update Posted (Actual)

May 1, 2017

Last Update Submitted That Met QC Criteria

April 26, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Pedometer-plus-email

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on pedometer-plus-email

3
Subscribe